Coronavirus vaccines are lucrative business
Pfizer and Biontech's Covid-19 vaccine is expected to sell for more than DKK 100bn in just 2020. However, Pfizer's story is also one of a company whose history involves corruption scandals.
BY BENJAMIN WERNER CHRISTENSEN AND SIGNE FERSLEV PEDERSEN, TRANSLATED BY NIELSINE NIELSEN
The world has been calling for a vaccine more or less since the Covid-19 epidemic first broke out in Asia, and later on in the Western world, and the world's leading vaccine developers have not had to look very hard to find the motivation to develop a vaccine for this virus.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Moderna reveals price of coronavirus vaccine
For subscribers
.jpg&w=384&q=75)
